Psyence Group Inc. (PSYG.CN)

0.0200 -0.0050 (-20.00%) At close: 11:11AM EDT

Psyence Group Inc.

121 Richmond Street West
Penthouse Suite, 1300
Toronto, ON M5H 2K1
Canada

https://www.psyence.com

Sector(s): Healthcare
Industry: Drug Manufacturers - General
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Jody Aufrichtig	Co-Founder & Executive Chairman	150k	N/A	1974
Mr. Alan Mark Friedman B.Com., Bcomm, Bproc Law	Co-Founder & Director	N/A	N/A	1972
Adri Botha	Interim Chief Financial Officer	N/A	N/A	N/A
Ms. Taryn Vos	General Counsel	N/A	N/A	N/A
Mr. Tony Budden	Chief Strategy Officer	N/A	N/A	N/A
Ms. Mary-Elizabeth Gifford	Executive Vice President for Public Policy & Global Impact	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Psyence Group Inc., a life science biotechnology company, engages in the commercial psilocybin mushroom cultivation and production activities. Its natural psilocybin is used for the treatment of a range of mental health disorders and other medical conditions. The company is developing pharmaceutical preparations of psilocybin doses to help heal psychological trauma and diagnosable disorders, including anxiety, depression, post-traumatic stress disorder, and grief and bereavement. It also focuses on the development, distribution, and sale of over-the-counter non psilocybin containing functional mushroom nutraceutical products under the GOODMIND brand. The company was founded in 2019 and is based in Toronto, Canada.

Corporate governance

Psyence Group Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.